/PRNewswire/ Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum.
DUBLIN, March 13, 2023 /PRNewswire/ Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants
Men Can Document Their Penile Curvature, Complete a Self-Assessment Questionnaire, Learn About Peyronie's Disease and Find a Provider Through the App - Peyronie's Disease assessment and